Lymna-DF-amide 2 is a neuropeptide variant characterized by an RFamide signature associated with gastropod behavioral modulation. Its sequence supports conformational studies relating to receptor binding. Researchers use it to analyze structural determinants in invertebrate neuromodulatory systems. The peptide aids mapping of conserved signaling motifs.
CAT No: L14002
1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
3. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More